4CPS-121 Impact of pharmaceutical consultations for new oral oncology agents

BACKGROUND: Pharmaceutical consultations are organised in the Department of Oncology when new oral anticancer drugs are prescribed. Drug-drug interactions (DDI) and drug-food interactions are frequent with these new drugs and can produce serious adverse events (SAE). Due to the chronicity of the dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Talarmin, C, Grajozsex, M, Houari, S, Clou, E, Fillon, J, Tendjaoui, F, Grazziotin-Soares, D, Lotz, JP, Gohari, A, Debrix, I
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Section 4: Clinical pharmacy services
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535313/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.212
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados